Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Protein Kinase Inhibitors"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%221474-0338%22+OR+%221744-764X%22&type=ISN&filter%5B%5D=topic_facet%3A%22Protein+Kinase+Inhibitors%22
/vufind/Search/Results?lookfor=%221474-0338%22+OR+%221744-764X%22&type=ISN&filter%5B%5D=topic_facet%3A%22Protein+Kinase+Inhibitors%22
Search /vufind/Search2/Results?lookfor=%221474-0338%22+OR+%221744-764X%22&type=ISN&filter%5B%5D=topic_facet%3A%22Protein+Kinase+Inhibitors%22
PubPharm (71)
1
A safety review of tyrosine kinase inhibitors for chronic myeloid leukemia
enthalten in:
Expert opinion on drug safety
| 2024
von
Özmen, D.
|
Alpaydın, D.
|
Saldoğan, M.
| +1
Wird geladen...
2
Comparative efficacy and safety of different doses of ponatinib versus other tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia : a systematic review and network meta-analysis
enthalten in:
Expert opinion on drug safety
| 2024
von
Zhang, S.
|
Lai, H.
|
Chen, H.
| +3
Wird geladen...
3
Thromboembolism profiles associated with cyclin-dependent kinase 4/6 inhibitors : a real-world pharmacovigilance study and a systematic review
enthalten in:
Expert opinion on drug safety
| 2023
von
Gao, S.
|
Li, Y.
|
He, Z.
| +8
Wird geladen...
4
Interstitial lung disease and CDK4/6 inhibitors in the treatment of breast cancer
enthalten in:
Expert opinion on drug safety
| 2023
von
Schlam, I.
|
Giordano, A.
|
Tolaney, S.
Wird geladen...
5
Pharmacovigilance analysis of cardiac risks associated with Bruton tyrosine kinase inhibitors
enthalten in:
Expert opinion on drug safety
| 2023
von
Zhai, Y.
|
Hu, F.
|
Shi, W.
| +6
Wird geladen...
6
Risks of cardiovascular toxicities associated with ALK tyrosine kinase inhibitors in patients with non-small-cell lung cancer : a meta-analysis of randomized control trials
enthalten in:
Expert opinion on drug safety
| 2023
von
Zhao, J.
|
Ma, Z.
|
Li, H.
| +4
Wird geladen...
7
Safety of current treatment options for NTRK fusion-positive cancers
enthalten in:
Expert opinion on drug safety
| 2023
von
Yang, A.
|
Laetsch, T.
Wird geladen...
8
Cardiac arrhythmias associated with anaplastic lymphoma kinase (ALK) inhibitors : an analysis of the FDA Adverse Event Reporting System (FAERS)
enthalten in:
Expert opinion on drug safety
| 2023
von
Wang, F.
|
Xu, G.
|
Wu, X.
Wird geladen...
9
Interstitial lung disease risk of anaplastic lymphoma kinase tyrosine kinase inhibitor treatment of non-small cell lung cancer : a real-world pharmacovigilance study
enthalten in:
Expert opinion on drug safety
| 2023
von
Zhao, M.
|
Liu, S.
|
Xie, R.
| +2
Wird geladen...
10
An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma
enthalten in:
Expert opinion on drug safety
| 2023
von
Rosellini, M.
|
Tassinari, E.
|
Marchetti, A.
| +5
Wird geladen...
1
2
3
4
5
6
7
8
Nächster »
[8]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Protein Kinase Inhibitors
Medienart
71
Aufsätze
71
E-Artikel
71
E-Ressourcen
Zeitschriftentitel
71
Expert opinion on drug safety
Thema
Protein Kinase Inhibitors
68
Journal Article
56
Review
38
Antineoplastic Agents
31
EC 2.7.10.1
18
safety
13
Protein-Tyrosine Kinases
11
tyrosine kinase inhibitor
8
ErbB Receptors
7
Pyrimidines
6
Anaplastic Lymphoma Kinase
6
Comparative Study
6
EC 2.7.11.1
6
Imidazoles
6
Phenylurea Compounds
6
Tyrosine Kinase Inhibitors
5
Angiogenesis Inhibitors
5
Meta-Analysis
5
NSCLC
5
Quinazolines
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
25
2020-
45
2010-2019
1
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
71
Englisch
Haven't found what you're looking for?
Wird geladen...